[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]. [electronic resource]
Producer: 20090611Description: 27-30 p. digitalISSN:- 1438-8820
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- administration & dosage
- Benzenesulfonates -- administration & dosage
- Bevacizumab
- Carcinoma, Renal Cell -- drug therapy
- Chemotherapy, Adjuvant
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Humans
- Indoles -- administration & dosage
- Kidney -- pathology
- Kidney Neoplasms -- drug therapy
- Neoadjuvant Therapy
- Neoplasm Metastasis
- Nephrectomy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Protein Kinase Inhibitors -- administration & dosage
- Pyridines -- administration & dosage
- Pyrroles -- administration & dosage
- Risk Assessment
- Risk Factors
- Sirolimus -- administration & dosage
- Sorafenib
- Sunitinib
- Time Factors
No physical items for this record
Publication Type: Comparative Study; Consensus Development Conference; Journal Article
There are no comments on this title.
Log in to your account to post a comment.